PODD - Insulet Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
86.42
+1.53 (+1.80%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close84.89
Open85.15
Bid0.00 x 0
Ask0.00 x 0
Day's Range84.99 - 86.51
52 Week Range38.43 - 89.63
Volume253,591
Avg. Volume443,900
Market Cap5.072B
Beta1.42
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit11 days ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on February 9. Over the last one-month, outflows of investor capital in ETFs holding PODD totaled $26 million.

  • Thomson Reuters StreetEvents17 days ago

    Edited Transcript of PODD presentation 7-Mar-17 4:35pm GMT

    Insulet Corp at Raymond James Institutional Investors Conference

  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit17 days ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    Insulet Corp NASDAQ/NGS:PODD

  • Benzinga2 months ago

    Analyst: Insulet On Track For Profitability In 2018

    Insulet Corporation (NASDAQ: PODD ) is up 80.5 percent year-over-year, and even last quarter’s bottom-line miss can’t deter the biotech’s bulls . The Rating BMO Capital Markets analyst Joanne Wuensch initiated ...

  • Why Abiomed’s Product Pipeline Looks Promising
    Market Realist2 months ago

    Why Abiomed’s Product Pipeline Looks Promising

    Abiomed (ABMD) is strategically focused on the market penetration of the company’s family of Impella heart pumps. The Impella device portfolio consists of Impella 2.5, Impella CP, Impella RP, Impella LD, and Impella 5.0 devices. To this end, Abiomed discontinued the sale of its AB5000 device used for heart surgery.

  • What Analysts Recommend for Abiomed and Peers in February 2018
    Market Realist2 months ago

    What Analysts Recommend for Abiomed and Peers in February 2018

    Abiomed (ABMD) is a supplier of mechanical circulatory support devices and offers a continuum of care to heart failure patients. Abiomed develops, manufactures, and commercializes products designed to improve the blood flow and perform the pumping function of the heart. Of the ten analysts covering Abiomed (ABMD) in February 2018, five analysts have given the stock a “strong buy” rating, three analysts have given it a “buy” rating, while two analysts have given it a “hold” rating.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PODD earnings conference call or presentation 21-Feb-18 9:30pm GMT

    Q4 2017 Insulet Corp Earnings Call

  • Analysts’ Ratings for NxStage Medical and Peers in February 2018
    Market Realist2 months ago

    Analysts’ Ratings for NxStage Medical and Peers in February 2018

    Headquartered in Lawrence, Massachusetts, NxStage Medical (NXTM) is a medical technology company with a focus on developing, manufacturing, and marketing innovative products targeted at patients suffering from chronic or acute kidney failure. The company also operates NxStage kidney care dialysis centers, which treat end-stage renal disease (or ESRD) patients. NxStage Medical’s primary product is System One, which is capable of delivering the therapeutic flexibility and clinical benefits of traditional dialysis machines in a smaller, portable, and easy-to-use format.

  • Insulet Pumps Out 26% Revenue Growth; Loss Narrows
    Motley Fool2 months ago

    Insulet Pumps Out 26% Revenue Growth; Loss Narrows

    The tubeless insulin pump specialist capped off a strong 2017 with a solid fourth quarter.

  • Associated Press2 months ago

    Insulet reports 4Q loss

    On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 12 cents. The results did not meet Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks ...

  • Benzinga2 months ago

    Insulet Q4 Earnings Preview

    Insulet (NASDAQ: PODD ) releases its next round of earnings Wednesday. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report. Earnings and Revenue Insulet's per-share ...

  • BDX’s Planned Product Launches in 2018
    Market Realist2 months ago

    BDX’s Planned Product Launches in 2018

    Becton Dickinson's Fiscal 1Q18 Results Beat Analyst Estimates

  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit3 months ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 7. Index (PMI) data, output in the Healthcare sector is rising.

  • J&J’s Medical Device Segment Registered Strong Growth in 4Q17
    Market Realist3 months ago

    J&J’s Medical Device Segment Registered Strong Growth in 4Q17

    Johnson & Johnson (JNJ) released its 4Q17 and fiscal 2017 results on January 23, 2018. The company reported sales growth across its three business segments: Pharmaceuticals, Medical Devices, and Consumer Businesses. The company’s medical device business contributed ~35% to J&J’s total sales in fiscal 4Q17.

  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit3 months ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 22. Over the last one-month, outflows of investor capital in ETFs holding PODD totaled $89 million.

  • Does Insulet Corporation’s (NASDAQ:PODD) Past Performance Indicate A Stronger Future?
    Simply Wall St.3 months ago

    Does Insulet Corporation’s (NASDAQ:PODD) Past Performance Indicate A Stronger Future?

    Analyzing Insulet Corporation’s (NASDAQ:PODD) track record of past performance is a valuable exercise for investors. It enables us to reflect on whether or not the company has met expectations, whichRead More...

  • Markit4 months ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 8. Over the last one-month, outflows of investor capital in ETFs holding PODD totaled $3.72 billion.

  • Here's Why Insulet Corporation Jumped Today
    Motley Fool4 months ago

    Here's Why Insulet Corporation Jumped Today

    Shares soar after management announced a big reimbursement win.

  • Benzinga4 months ago

    4 Tailwinds Driving Raymond James' Insulet Bull Case

    Raymond James identified four major tailwinds for Insulet Corporation (NASDAQ: PODD ) that the firm said could help drive 20-percent-plus revenue growth over the next two years. The Analyst Raymond James ...

  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit4 months ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on December 14. Index (PMI) data, output in the Healthcare sector is rising.

  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit5 months ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • Capital Cube5 months ago

    ETFs with exposure to Insulet Corp. : November 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Insulet Corp. Here are 5 ETFs with the largest exposure to PODD-US. Comparing the performance and risk of Insulet Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Insulet Corp.
    Markit5 months ago

    See what the IHS Markit Score report has to say about Insulet Corp.

    This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on November 7. Index (PMI) data, output in the Healthcare sector is rising.

  • Capital Cube5 months ago

    ETFs with exposure to Insulet Corp. : November 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Insulet Corp. Here are 5 ETFs with the largest exposure to PODD-US. Comparing the performance and risk of Insulet Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)